Evidence map›Paper›PMID 40849472›Full record

ArticleBMC urology2025

Patients' experiences of a standardized care pathway for suspected bladder cancer due to macroscopic hematuria.

Lisa Karlsson, Anette Ek-Steinum, Viola Nyman, Suleiman Abuhasanein

Abstract read
In one paragraph

Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lisa KarlssonDepartment of Surgery, Urology section, NU Hospital Group, Region Västra Götaland, Uddevalla, Sweden.
Anette Ek-SteinumDepartment of Surgery, Urology section, NU Hospital Group, Region Västra Götaland, Uddevalla, Sweden.
Viola NymanDepartment of Health Sciences, University West, Trollhättan, Sweden.
Suleiman AbuhasaneinDepartment of Surgery, Urology section, NU Hospital Group, Region Västra Götaland, Uddevalla, Sweden. suleiman.abuhasanein@gu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore patients' experiences navigating the Standardized Care Pathway (SCP) for macroscopic hematuria through semi-structured interviews. METHODS AND MATERIALS: An interview study was conducted to explore patients' experiences of SCP for macroscopic hematuria. The study employed content analysis with an inductive approach, as described by Lundman and Graneheim, to explore both explicit and implicit patterns in the data. Informants were recruited from an outpatient clinic for investigation of macroscopic hematuria, with interview questions derived from literature and clinical experience. Researchers immersed themselves in the data through repeated readings of transcripts, identifying meaning units that were coded and analyzed to develop subcategories reflecting similarities and differences.

resultsTwelve patients, with a median age of 71 years (58% women), participated in the study. Among them, one was diagnosed with urinary bladder cancer (UBC). The findings highlight a mix of appreciation and questioning associated with the SCP process, as patients valued the efficiency of one stop policy for testing but also experienced heightened anxiety. A lack of detailed and patient-centred communication emerged as a key issue, with primary care centers providing insufficient information.

conclusionsAlthough SCP is effective, it prompts consideration of whether it is suitable for all patients. A more individually tailored approach might be more appropriate, prioritizing rapid evaluation for those with a high likelihood of cancer while directing others to a standard diagnostic route. Continuing the one-stop policy was seen as beneficial.

Indexed as

Critical PathwaysHematuriaPatient SatisfactionUrinary Bladder NeoplasmsAgedAged, 80 and overFemaleHumansMaleMiddle AgedContent analysisHematuriaInterviewPatients' experiencesUrinary bladder cancer

Identifiers

PMID40849472
PMCPMC12374357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.